Casey Means' Nomination as U.S. Surgeon General Stalled in Senate

Casey Means, President Donald Trump's nominee for U.S. Surgeon General, faces significant hurdles in the Senate, reflecting a growing reluctance among some Republican lawmakers regarding the more controversial aspects of the "Make America Healthy Again" (MAHA) agenda. Despite the surgeon general's influential role in public health advocacy, Means' nomination has stalled more than a month after her confirmation hearing before the Senate Committee on Health, Education, Labor and Pensions (HELP). There are currently no plans to bring her nomination to a vote.

The Hill

Means, a health influencer with an expired medical license, has drawn criticism for her qualifications. Mark Brewer, a political science professor, noted that her lack of public health experience raises concerns among senators. Jerome Adams, a former surgeon general, echoed this sentiment, suggesting that her confirmation could send an undesirable message about the qualifications necessary for such a pivotal role.

The Hill

The nomination has seen pushback from key Republican senators, including Bill Cassidy (La.), Lisa Murkowski (Alaska), and Susan Collins (Maine). Cassidy, the HELP Committee chair, has previously faced Trump's ire for his impeachment vote, while Murkowski and Collins have expressed reservations about Means' views on vaccinations and her reported use of psilocybin mushrooms. The White House, however, has defended Means, with press secretary Karoline Leavitt asserting her qualifications as an alumna of Stanford University and the Stanford School of Medicine.

The Hill

Opposition to Means' nomination extends beyond the Senate. The political action organization Stand Up For Science has mobilized medical professionals to voice their concerns, emphasizing the need for a surgeon general who can credibly advocate for health initiatives. Ryan Cole, head of medical and scientific affairs for the Independent Medical Alliance, stated that Means failed to convince senators of her ability to effectively communicate health benefits, particularly as the midterms approach.

The Hill

There is a notable divide among Republican senators regarding Means' confirmation. While Cassidy, Collins, and Murkowski have not committed to supporting her, other senators, such as Thom Tillis (R-N.C.), have indicated they would likely oppose her nomination if it reaches a floor vote. The uncertainty surrounding Means' confirmation reflects broader tensions within the GOP, particularly as the party navigates the upcoming midterm elections.

The Hill

In response to Trump's earlier comments about potentially withdrawing Means' nomination, the White House reaffirmed its support, urging the Senate to expedite her confirmation. The MAHA Action PAC has also been actively lobbying for her nomination, emphasizing the importance of having a surgeon general who aligns with their health initiatives.

The Hill

As the Senate continues to deliberate, the future of Casey Means' nomination remains uncertain. With the midterm elections looming and internal party dynamics at play, Republican senators may be increasingly cautious about confirming a nominee who could further complicate their political landscape.

The Hill